PULMONARY EMBOLISM AFTER SURGICAL RESECTION OF A MENINGIOMA

Vestnik ◽  
2021 ◽  
pp. 118-121
Author(s):  
Е.К. Дюсембеков ◽  
Е.Б. Алгазиев ◽  
А.К. Жанисбаев ◽  
С.М. Анартаев ◽  
И.А. Канлов ◽  
...  
Keyword(s):  
Pulmonary Embolism ◽  
Deep Vein Thrombosis ◽  
Surgical Resection ◽  
Anticoagulant Therapy ◽  
Clinical Case ◽  
Massive Pulmonary Embolism ◽  
Multidisciplinary Teams ◽  
Vein Thrombosis ◽  
Surgical Methods ◽  
Deep Vein

В статье представлен клинический случай успешного лечения острой массивной тромбоэмболии лёгочной артерии у пациента после удаления менингиомы. Известно, что частота тромбозов глубоких вен нижних конечностей (ТГВ) в нейрохирургической практике достаточно высока, и может достигать 25-34%. ТГВ является основной причиной более грозной тромбоэмболии легочной артерии (ТЭЛА), частота которой составляет от 1,5% до 3%. На сегодняшний день медицина располагает несколькими эффективными инструментами лечения пациентов с ТЭЛА: от антикоагулянтной терапии до хирургических методов реперфузии. Благодаря слаженной работе в современных многопрофильных клиниках интервенционных кардиохирургов, реаниматологов и нейрохирургов, обеспечивающих своевременную и высокоспециализированную помощь, становится возможным спасение жизней пациентов даже с такой тяжелой и жизнеугрожающей патологией как острая массивная тромбоэмболия легочных артерий. The article presents a clinical case of successful treatment of acute massive pulmonary embolism in a patient after resection of a meningioma. The incidence of Deep vein thrombosis (DVT) in neurosurgical practice is astonishingly high as it might reach 25-34% in some reports, and represents the first cause for pulmonary embolism (PE), which incidence is thought to be between 1,5% and 3%. Nowadays there are several options for treating patients with pulmonary embolism: from anticoagulant therapy to surgical methods of reperfusion. Effective multidisciplinary teams and coordinated team in our clinics can save the lives of people with pulmonary embolism.

The Risk and Efficacy of Anticoagulant Therapy in the Treatment of Thromboembolic Complications in Patients with Primary Malignant Brain Tumors

Neurosurgery ◽  
1990 ◽  
Vol 27 (1) ◽  
pp. 74-77 ◽  
Author(s):  
Eric Altschuler ◽  
Hans Moosa ◽  
Robert G. Selker ◽  
Frank T. Vertosick
Keyword(s):  
Pulmonary Embolism ◽  
Deep Vein Thrombosis ◽  
Anticoagulant Therapy ◽  
Warfarin Therapy ◽  
Oral Anticoagulant Therapy ◽  
Effective Means ◽  
Thromboembolic Complications ◽  
Intratumoral Hemorrhage ◽  
Vein Thrombosis ◽  
Deep Vein

Abstract Twenty-three patients with malignant glial neoplasms were treated with anticoagulant therapy for thromboembolic complications. Fifteen patients had deep vein thrombosis alone, and 8 patients had both deep vein thrombosis and pulmonary embolism. Serum prothrombin times were maintained at 1.25 times control for an average of 5.8 months per patient, for a total patient exposure to warfarin therapy of 132 patient-months (11 patient-years). Only 1 patient suffered a recurrent pulmonary embolism, and this occurred during an episode of gastrointestinal bleeding, when anticoagulant therapy had to be discontinued prematurely. All patients were followed with serial computed tomographic or magnetic resonance imaging scans, and no patient showed radiographic evidence of intratumoral hemorrhage either during or after warfarin therapy. One patient, who died from a large recurrent glioblastoma, was found at autopsy to have scattered foci of intratumoral hemorrhage. This series, together with a review of the available literature, suggests that oral anticoagulant therapy is both a safe and effective means of treating thromboembolic complications in patients with residual malignant glial tumors.

Massive Pulmonary Embolism Complicating Streptokinase Treatment for Deep Vein Thrombosis

Respiration ◽  
1987 ◽  
Vol 52 (1) ◽  
pp. 54-58 ◽  
Author(s):  
Catherine S.H. Sassoon ◽  
Teresita T. Te ◽  
Richard W. Light
Keyword(s):  
Pulmonary Embolism ◽  
Deep Vein Thrombosis ◽  
Massive Pulmonary Embolism ◽  
Vein Thrombosis ◽  
Deep Vein

Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism

Blood ◽  
2014 ◽  
Vol 123 (12) ◽  
pp. 1794-1801 ◽  
Author(s):  
Clive Kearon ◽  
Elie A. Akl
Keyword(s):  
Pulmonary Embolism ◽  
Deep Vein Thrombosis ◽  
High Risk ◽  
Anticoagulant Therapy ◽  
Low Risk ◽  
Risk Of Recurrence ◽  
Vein Thrombosis ◽  
Risk Of Bleeding ◽  
Deep Vein

Abstract It takes about 3 months to complete “active treatment” of venous thromboembolism (VTE), with further treatment serving to prevent new episodes of thrombosis (“pure secondary prevention”). Consequently, VTE should generally be treated for either 3 months or indefinitely (exceptions will be described in the text). The decision to stop anticoagulants at 3 months or to treat indefinitely is dominated by the long-term risk of recurrence, and secondarily influenced by the risk of bleeding and by patient preference. VTE provoked by a reversible risk factor, or a first unprovoked isolated distal (calf) deep vein thrombosis (DVT), has a low risk of recurrence and is usually treated for 3 months. VTE associated with active cancer, or a second unprovoked VTE, has a high risk of recurrence and is usually treated indefinitely. The decision to stop anticoagulants at 3 months or to treat indefinitely is more finely balanced after a first unprovoked proximal DVT or pulmonary embolism (PE). Indefinite anticoagulation is often chosen if there is a low risk of bleeding, whereas anticoagulation is usually stopped at 3 months if there is a high risk of bleeding. The decision to continue anticoagulation indefinitely after a first unprovoked proximal DVT or PE is strengthened if the patient is male, the index event was PE rather than DVT, and/or d-dimer testing is positive 1 month after stopping anticoagulant therapy.

scholarly journals The Case Deep Vein Thrombosis and Massive Pulmonary Embolism in Patient with Achondroplasia

2019 ◽  
Vol 20 (-1) ◽  
pp. 356-356
Author(s):  
Serif Kurtulus ◽  
◽  
Remziye Can ◽  
Mehmet Kolu ◽  
Zafer Hasan Ali Sak ◽  
...  
Keyword(s):  
Pulmonary Embolism ◽  
Deep Vein Thrombosis ◽  
Massive Pulmonary Embolism ◽  
Vein Thrombosis ◽  
Deep Vein
Sign in / Sign up

Export Citation Format

Share Document